drugset / Trial / NCT00635622

Safety and Efficacy Study of Lactobacillus Administered Vaginally in Women With Bacterial Vaginosis

NCT00635622

RandomizedParallel-groupQuadruple-blind

Summary

This is a phase IIa clinical trial in women with bacterial vaginosis. This study will determine whether treatment with vaginal lactobacillus in combination with antibiotic therapy (metronidazole) is effective in colonizing the vagina with the lactobacillus bacteria found in normal vaginal flora.

Timeline

Start
2008-04
Primary completion
2009-01
Completion
2009-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject LACTIN-V Other / unclassified 2e+09 unknown Other

Indications